Skip to content

EV / sales at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
+0.1×
Revvity logo
RevvityRVTY
4.4×-0.9×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.1×+0.1×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
4.9×+0.7×
IQVIA logo
IQVIAIQV
2.6×-0.3×
TEC
Bio-TechneTECH
6.8×-1.1×

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

Based on the most recent quarter.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's EV / sales?
Charles River Laboratories (CRL) reported EV / sales of 2.8× in Q1 2026.
How has Charles River Laboratories's EV / sales changed year-over-year?
Charles River Laboratories's EV / sales increased by 8.3% year-over-year, from 2.6× to 2.8×.
What is the long-term trend for Charles River Laboratories's EV / sales?
Over 5 years (2020 to 2025), Charles River Laboratories's EV / sales has grown at a -9.3% compound annual growth rate (CAGR), from 5× to 3.1×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.